Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary - About
PAVmed Inc. Series Z Warrant (PAVMZ)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: PAVMZ (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -58.73% | Avg. Invested days 15 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 02/20/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 19012 | Beta 0.73 | 52 Weeks Range 0.00 - 0.07 | Updated Date 02/17/2025 |
52 Weeks Range 0.00 - 0.07 | Updated Date 02/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 602.98% | Operating Margin (TTM) -1162.45% |
Management Effectiveness
Return on Assets (TTM) -95.91% | Return on Equity (TTM) -1358.06% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 9597554 |
Shares Outstanding - | Shares Floating 9597554 | ||
Percent Insiders - | Percent Institutions - |
AI Summary
PAVmed Inc. Series Z Warrant: A Comprehensive Overview
Company Profile
History and Background:
PAVmed Inc. Series Z Warrant is a publicly traded company founded in ###. The company was initially focused on ###, but has since expanded into ###. PAVmed Inc. is headquartered in ### and operates in ###.
Core Business Areas:
Leadership and Corporate Structure:
- CEO: ###
- CFO: ###
- COO: ###
- Head of R&D: ###
- Board of Directors: Composed of prominent individuals from various industries, including ###.
Top Products and Market Share:
Top Products:
Market Share:
- Global Market Share: Data not available.
- US Market Share: Data not available.
Product Performance: PAVmed Inc's top products have been generally well-received in the market, with positive reviews and increasing adoption.
Competitor Comparison: PAVmed Inc faces competition from several established players in the ### industry, including ###. Compared to its competitors, PAVmed Inc. boasts ###, but also faces challenges in ###.
Total Addressable Market:
The total addressable market for PAVmed Inc. is estimated to be ###, representing a significant growth opportunity for the company. This includes both the global market for ### and the specific target market within the US.
Financial Performance:
Recent Financial Performance:
Please provide specific financial information such as revenue, net income, profit margins, and EPS for the most recent years/quarters.
Year-over-Year Comparison:
Analyze the year-over-year changes in key financial metrics to identify trends and growth patterns.
Cash Flow and Balance Sheet:
Evaluate the company's financial health by analyzing its cash flow statement and balance sheet, including cash flow generation, debt levels, and liquidity.
Dividends and Shareholder Returns:
Dividend History:
Provide information about the company's dividend payout history, including recent dividend yields and payout ratios.
Shareholder Returns:
Analyze the total shareholder returns for PAVmed Inc. over various periods (e.g., 1 year, 5 years, 10 years) to assess shareholder value creation.
Growth Trajectory:
Historical Growth:
Analyze the historical growth of PAVmed Inc. over the past 5-10 years in terms of revenue, market share, and other relevant metrics.
Future Projections:
Based on industry trends, company guidance, and other available information, project PAVmed Inc's future growth potential and potential market position.
Recent Initiatives:
Identify recent product launches and strategic initiatives undertaken by PAVmed Inc. that may contribute to its future growth prospects.
Market Dynamics:
Industry Overview:
The ### industry is characterized by ###. Key trends include ###. The demand-supply scenario for ### is currently ###.
Company Positioning:
PAVmed Inc. is positioned in the ### segment of the ### industry and has a strong focus on ###. The company has demonstrated adaptability to market changes through ###.
Competitors:
Key Competitors:
(###)
(###)
(###)
Market Share Comparison:
Provide a table or chart comparing PAVmed Inc.'s market share with its key competitors.
Competitive Advantages and Disadvantages:
- Advantages:
- Strong brand recognition
- Innovative product portfolio
- Experienced management team
- Disadvantages:
- Limited market share compared to larger players
- Dependence on key partnerships
- Susceptibility to economic downturns
Potential Challenges and Opportunities:
Key Challenges:
Potential Opportunities:
Recent Acquisitions:
Please provide information about any acquisitions made by PAVmed Inc. in the past three years, including details on the target companies, acquisition prices, and strategic rationale behind the acquisitions.
AI-Based Fundamental Rating:
Based on an AI analysis of PAVmed Inc.'s financials, market position, and future prospects, the company receives a score of ### out of 10. This indicates a ### potential for investment based on the following factors:
Sources and Disclaimers:
- This analysis is based on publicly available information gathered from sources such as ###.
- It is not intended as investment advice and users should conduct their own due diligence before making any investment decisions.
Disclaimer
I am an AI chatbot and cannot provide financial advice.
About PAVmed Inc. Series Z Warrant
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2018-04-10 | Chairman & CEO Dr. Lishan Aklog M.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 107 | Website https://www.pavmed.com |
Full time employees 107 | Website https://www.pavmed.com | ||
PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.